It’s no secret that drug development is a huge gamble for pharmaceutical companies. The process involves betting billions of dollars and more than a decade of time that a compound will beat the 90% ...

Everus Construction Group (NYSE:ECG) delivered second-quarter results that beat expectations, with earnings and revenue both coming in ahead of analyst forecasts. The company credited demand from data ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how Viz HCM enables faster, accurate detection of hypertrophic ...